Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Name: Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Published: 2015
License: Public Domain

Sumitomo Pharma America, Inc. · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

parkinson-disease

parkinson disease, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Related documents